Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
29 hedge funds and large institutions have $1.04M invested in Lucira Health, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 28 → 29 (+1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
96% less capital invested
Capital invested by funds: $24.2M → $1.04M (-$23.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$43.5K |
| 2 |
LRPA
L. Roy Papp & Associates
Phoenix,
Arizona
|
+$23.1K |
| 3 |
Renaissance Technologies
New York
|
+$18.5K |
| 4 |
Jane Street
New York
|
+$17.1K |
| 5 |
FPAS
Focus Partners Advisor Solutions
Saint Louis,
Missouri
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$8.3M |
| 2 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$339K |
| 3 |
Citigroup
New York
|
-$116K |
| 4 |
CPWM
Cypress Point Wealth Management
Dallas,
Texas
|
-$41K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$35.2K |
LHDX Hedge Fund Activity: Q4 2022 in Review
29 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q4 2022, worth a combined $1.04M — down 96% from $24.2M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LHDX positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 11 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $43.5K. The largest seller was EPIQ Capital Group, cutting an estimated $8.3M.
- 29 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $1.04M of Lucira Health, Inc. Common Stock stock for Q4 2022, down 96% quarter-over-quarter.
- 5 funds opened new Lucira Health, Inc. Common Stock positions in Q4 2022 and 4 closed out, a net change of +1 holder.
- The largest Lucira Health, Inc. Common Stock buyer in Q4 2022 was Virtu Financial, an estimated $43.5K added.
- The largest Lucira Health, Inc. Common Stock seller in Q4 2022 was EPIQ Capital Group, an estimated $8.3M sold.
Based on aggregated 13F filings for Q4 2022.